| Mirela Carter, MD | |
|
412 Se 11th St, Anadarko, OK 73005-4442 | |
| (405) 247-9500 | |
| (405) 247-9505 |
| Full Name | Mirela Carter |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 412 Se 11th St, Anadarko, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699817205 | NPI | - | NPPES |
| 200131280A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24605 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mirela Carter, MD Po Box 6245, Edmond, OK 73083-6245 Ph: (405) 562-4221 | Mirela Carter, MD 412 Se 11th St, Anadarko, OK 73005-4442 Ph: (405) 247-9500 |
News Archive
Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.
Boston Scientific Corporation announces two-year results from the PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness outcomes for the 2.25 mm PROMUS Element Everolimus-Eluting Platinum Chromium (PtCr) Stent System in treating de novo coronary lesions in small coronary vessels.
Xellia Pharmaceuticals, a fully integrated specialty pharmaceutical company focusing on the global anti-infective market, announced today that it is developing new antibiotics effective against multi-drug resistant (MDR), Gram-negative bacteria.
Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.
MELA Sciences, Inc., designer and developer of MelaFind®, an FDA and CE Mark approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage, participated in a two-day hands-on skin cancer diagnostics workshop in Augsburg, Germany, where leading dermatologists examined "high-risk" melanoma patients with MelaFind® and also participated in an imaging devices exhibit.
› Verified 6 days ago
Jay C Belt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1104 E Central Blvd, Anadarko, OK 73005 Phone: 405-247-6685 Fax: 405-247-2043 | |
Dr. Donald Thomas Brock, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 412 Se 11th St, Anadarko, OK 73005 Phone: 405-247-9500 | |
George A Cheek, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1104 E Central Blvd, Anadarko, OK 73005 Phone: 405-247-6685 Fax: 405-247-2043 | |
Alejandra De Santiago, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 718 W Petree Rd, Anadarko, OK 73005 Phone: 405-632-6688 |